CompoAtlas

HIUSVITA® HAIR, SKIN & NAILS(2018.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000375/2018
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
Sastamalan Ravinne Oy
Manufacturer
Pharmatech A.S.
Form
kapsula un tablete
Origin
Somija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
2 kapsulas un 2 tabletes
Published pack size
kapsula pa 1,1 g, tablete pa 0,85 g
Published packaging
pa 56 kapsulām un 56 tabletēm

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
C VITAMĪNSvitamins ; C VITAMĪNS ; 200 ; mgVitamine CVitamin or mineral
NIACĪNSvitamins ; NIACĪNS ; 20 ; mg NEVitamine B3 (niacine)Vitamin or mineral
BIOTĪNSvitamins ; BIOTĪNS ; 200 ; μgBiotine (vitamine B8)Vitamin or mineral
Cinksminerals ; Cinks ; 20 ; mgZincVitamin or mineral
Varšminerals ; Varš ; 1000 ; μgCuivreVitamin or mineral
Selēnsminerals ; Selēns ; 54 ; μgSéléniumVitamin or mineral
Rozmarīna lapu ekstraktsplants ; Rozmarīna lapu ekstrakts ; Rosmarinus officinalis ; 200 ; mgrosmarinus officinalisPlant
Grieķu trigonellas sēklu ekstraktsplants ; Grieķu trigonellas sēklu ekstrakts ; Trigonella foenum-graecum ; 200 ; mgtrigonella foenum-graecumPlant
Makadamijas riekstu eļļaotherIngredients ; Makadamijas riekstu eļļa ; 1500 ; mgNot recognisedRole not identified
Jūras izcelsmes kolagēnsotherIngredients ; Jūras izcelsmes kolagēns ; 400 ; mgNot recognisedRole not identified
MaltodekstrīnsotherIngredients ; MaltodekstrīnsNot recognisedRole not identified
Celuloze (E460)otherIngredients ; Celuloze (E460)Listed as food additive E 460 (EU Union list)Role not identified
Taukskābju magnija sāļi (E470b)otherIngredients ; Taukskābju magnija sāļi (E470b)Listed as food additive E 470b (EU Union list)Role not identified
Kalcija fofāts E341(iii)otherIngredients ; Kalcija fofāts E341(iii)Listed as food additive E 341 (EU Union list)Role not identified
Silīcija dioksīds (551)otherIngredients ; Silīcija dioksīds (551)Not recognisedRole not identified
Hidroksipropildicietes fosfāts (E1442)otherIngredients ; Hidroksipropildicietes fosfāts (E1442)Listed as food additive E 1442 (EU Union list)Role not identified
ŽelatīnsotherIngredients ; ŽelatīnsNot recognisedRole not identified
Glicerīns (E422)otherIngredients ; Glicerīns (E422)Listed as food additive E 422 (EU Union list)Role not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Norvēģija

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Rozmarīna lapu ekstrakts
    Read the warning, when it applies and the studies cited

    ROSEMARY – ROSMARINUS OFFICINALIS Oral

    Route of administration: Oral (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association’s Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 29 May 2026

    ROSEMARY - ROSMARINUS OFFICINALIS Topical

    Route of administration: Topical (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association’s Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have large open wounds, skin lesions, feverish conditions, acute inflammation, severe circulatory disorders or hypertension (ESCOP 2003).

    Sources cited by Health Canada (1)
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Barnes et al. 2007; ESCOP 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Health Canada monograph dated 29 May 2026

  • Grieķu trigonellas sēklu ekstrakts
    Read the warning, when it applies and the studies cited

    FENUGREEK - TRIGONELLA FOENUM-GRAECUM - Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Gardner and McGuffin 2013; Brinker 2010; Mills et al. 2006; Hoffman 2003; Blumenthal et al. 2000).

    Sources cited by Health Canada (4)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
    • Mills E, Duguoa J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation. An Evidence-Based Approach. New York (NY): Taylor and Francis; 2006.

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Health Canada monograph dated 29 May 2026

    FENUGREEK - TRIGONELLA FOENUM-GRAECUM - Topical

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 29 May 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “HIUSVITA® HAIR, SKIN & NAILS(2018.)”, https://compoatlas.com/en/supplements/latvia/7319-hiusvita-hair-skin-nails-2018, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line